Streetbeat News

Products Services

AAPL

GOOG

GOOGL

Apple Inc's launch of the Vision Pro headset has sparked renewed interest in the AR/VR sector, with the company positioning the device as a potential game-changer. Despite a high price tag and unclear release date, investors are focusing on the market validation that Vision Pro provides. However, some analysts caution that the AR/VR industry should not solely rely on Apple's success, citing Alphabet Inc's failed smart glasses project.

Portfolio Pulse from Anusuya Lahiri

July 26, 2023 | 12:35 pm

EWU

NVO

Britain's drug watchdog is investigating a class of drugs that includes Novo's diabetes medicine Ozempic and weight-loss treatment Saxenda following reports of suicidal thoughts.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 12:35 pm

HAS

MAT

WBD

Mattel, Inc. (NASDAQ:MAT) is set to report its Q2 results after the market close today. The company is expected to post a loss of $0.02 per share, compared to a profit of $0.18 a year ago. The revenue for the June quarter may have dropped 19% YoY to $1 billion. The company's stock has rallied since late June due to the Barbie movie craze. Mattel and Hasbro, Inc. (NASDAQ:HAS) announced a multi-year licensing agreement, which led to a rally in Mattel's stock. Warner Bros. Discovery, Inc.'s (NYSE:WBD) Barbie movie collected $155 million in domestic box office in the first three days, marking the highest opening in 2023.

Portfolio Pulse from Shanthi Rexaline

July 26, 2023 | 12:34 pm

ERIC

INTC

Ericsson (ERIC) has partnered with Intel Corp (INTC) to leverage Intel's 18A process and manufacturing technology for Ericsson's future 5G infrastructure. Intel will manufacture custom 5G SoCs for Ericsson. The companies will also expand their collaboration to optimize 4th Gen Intel Xeon Scalable processors for Ericsson's Cloud RAN solutions. Ericsson recently reported a 3% YoY sales growth to $6.125 billion, with a sharp decline in North American sales offset by strong sales in India.

Portfolio Pulse from Anusuya Lahiri

July 26, 2023 | 12:29 pm

AMRN

Amarin Corporation has announced that its latest research on the clinical benefits of VASCEPA/VAZKEPA will be presented at the European Society of Cardiology Congress.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 12:29 pm

AMRX

Amneal Pharmaceuticals has submitted Abbreviated New Drug Applications (ANDAs) to the U.S. FDA for three complex generics. The drugs include Albuterol sulfate inhalation, Bimatoprost ophthalmic solution, and Propofol emulsion, with U.S. IQVIA sales of $814 million, $779 million, and $311 million respectively.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 12:23 pm

ELYS

Elys Game Technology has announced a partnership with Santa Claran Casino Resort to launch the ELYS sportsbook. This partnership will allow the casino to offer sports betting to its customers.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 12:21 pm

EDAP

EDAP TMS has received approval for reimbursement in Switzerland for the use of its High-Intensity Focused Ultrasound (HIFU) in the treatment of prostate cancer. This approval could potentially increase the adoption of EDAP's HIFU technology in Switzerland.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 12:20 pm

ACLS

WOLF

Axcelis Technologies, Inc. (ACLS) has announced the shipment of its Purion H200 SiC Power Series Implanter to Wolfspeed, Inc. (WOLF). The implanter is designed to enhance the performance of silicon carbide power devices.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 12:15 pm

ABBV

AbbVie has announced the publication of results from its Phase 4 IMMpulse study of SKYRIZI, which achieved all primary and ranked secondary endpoints. This suggests a positive development in the company's drug pipeline.

Portfolio Pulse from Bill Haddad

July 26, 2023 | 12:09 pm